A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- NJACTS Community Engagement Core COVID-19 Resources
- N.J. Gov. Phil Murphy urges microplastics regulations in tap water. Can water providers meet the challenge?
- Could Hidden Infections Be Fueling Long COVID?
- Join NJ ACTS BERD on 1/22 for a Workshop with Dr. Yan Sun from NJIT
- How NJIT Graduate Student Jaimee Diogo Is Transforming STEM Futures Through ‘STEM Like a Girl’
Categories
- Community (2,427)
- Covid (996)
- CTO Events (6)
- News (3,073)
- Pilots (21)